NEW YORK (GenomeWeb News) – Life Technologies disclosed in a filing with the US Securities and Exchange Commission yesterday that it has requested a waiver under an existing credit agreement with lenders dated Nov. 21, 2008.

If approved, the waiver would enable Life Technologies to incur indebtedness in the form of unsecured, fixed-rate or floating-rate securities, in one or more series. The firm would use the proceeds to prepay term loan indebtedness under the credit agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.